APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Drug Monitoring

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Selected research

Industry Growth & Trends

Global Therapeutic Drug Monitoring Industry Growth and Trends Forecast to 2032

1 January 2026103 pages

Choose your research edition.

Industry ResearchTherapeutic Drug Monitoring Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Drug Monitoring Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Therapeutic Drug Monitoring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Drug Monitoring Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Drug Monitoring Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

According to APO Research, the global Therapeutic Drug Monitoring market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Therapeutic Drug Monitoring market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Drug Monitoring market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Drug Monitoring market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Therapeutic Drug Monitoring.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Therapeutic Drug Monitoring market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Drug Monitoring Market by Company

Roche

Danaher

Abbott

Thermo Fisher Scientific

Siemens Healthcare

Bio-Rad Laboratories

BioMerieux

Sanquin

Becton Dickinson

Quest Diagnostics

Therapeutic Drug Monitoring Segment by Type

Blood Test

Urine Test

Saliva Test

Other Test

Therapeutic Drug Monitoring Segment by Application

Hospital Labs

Private Labs

Others

Therapeutic Drug Monitoring Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Therapeutic Drug Monitoring companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Drug Monitoring Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Therapeutic Drug Monitoring Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Therapeutic Drug Monitoring Market Share by Region (2021-2026) Table 4. Global Therapeutic Drug Monitoring Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Therapeutic Drug Monitoring Market Share by Region (2027-2032) Table 6. Global Therapeutic Drug Monitoring Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Therapeutic Drug Monitoring Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Therapeutic Drug Monitoring Market Size Share by Type (2021-2026) Table 9. Global Therapeutic Drug Monitoring Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Therapeutic Drug Monitoring Market Size Share Forecasted by Type (2027-2032) Table 11. North America Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Therapeutic Drug Monitoring Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Therapeutic Drug Monitoring Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Therapeutic Drug Monitoring Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Therapeutic Drug Monitoring Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Therapeutic Drug Monitoring Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Therapeutic Drug Monitoring Market Size Share by Application (2021-2026) Table 24. Global Therapeutic Drug Monitoring Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Therapeutic Drug Monitoring Market Size Share Forecasted by Application (2027-2032) Table 26. North America Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Therapeutic Drug Monitoring Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Therapeutic Drug Monitoring Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Therapeutic Drug Monitoring Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Therapeutic Drug Monitoring Industry Trends Table 37. Therapeutic Drug Monitoring Industry Drivers Table 38. Therapeutic Drug Monitoring Industry Opportunities and Challenges Table 39. Therapeutic Drug Monitoring Industry Restraints Table 40. Global Therapeutic Drug Monitoring Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Therapeutic Drug Monitoring Revenue Market Share by Company (2021-2026) Table 42. Global Therapeutic Drug Monitoring Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Therapeutic Drug Monitoring Key Company Headquarters & Area Served Table 44. Global Therapeutic Drug Monitoring Company, Product Type & Application Table 45. Global Therapeutic Drug Monitoring Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Therapeutic Drug Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Roche Therapeutic Drug Monitoring Product Portfolio Table 52. Roche Recent Development Table 53. Danaher Company Information Table 54. Danaher Business Overview Table 55. Danaher Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Danaher Therapeutic Drug Monitoring Product Portfolio Table 57. Danaher Recent Development Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Abbott Therapeutic Drug Monitoring Product Portfolio Table 62. Abbott Recent Development Table 63. Thermo Fisher Scientific Company Information Table 64. Thermo Fisher Scientific Business Overview Table 65. Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio Table 67. Thermo Fisher Scientific Recent Development Table 68. Siemens Healthcare Company Information Table 69. Siemens Healthcare Business Overview Table 70. Siemens Healthcare Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio Table 72. Siemens Healthcare Recent Development Table 73. Bio-Rad Laboratories Company Information Table 74. Bio-Rad Laboratories Business Overview Table 75. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio Table 77. Bio-Rad Laboratories Recent Development Table 78. BioMerieux Company Information Table 79. BioMerieux Business Overview Table 80. BioMerieux Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. BioMerieux Therapeutic Drug Monitoring Product Portfolio Table 82. BioMerieux Recent Development Table 83. Sanquin Company Information Table 84. Sanquin Business Overview Table 85. Sanquin Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sanquin Therapeutic Drug Monitoring Product Portfolio Table 87. Sanquin Recent Development Table 88. Becton Dickinson Company Information Table 89. Becton Dickinson Business Overview Table 90. Becton Dickinson Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Becton Dickinson Therapeutic Drug Monitoring Product Portfolio Table 92. Becton Dickinson Recent Development Table 93. Quest Diagnostics Company Information Table 94. Quest Diagnostics Business Overview Table 95. Quest Diagnostics Therapeutic Drug Monitoring Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio Table 97. Quest Diagnostics Recent Development Table 98. North America Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Therapeutic Drug Monitoring Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Therapeutic Drug Monitoring Market Share by Country (2021-2026) Table 101. North America Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Therapeutic Drug Monitoring Market Share Forecast by Country (2027-2032) Table 103. Europe Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Therapeutic Drug Monitoring Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Therapeutic Drug Monitoring Market Share by Country (2021-2026) Table 106. Europe Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Therapeutic Drug Monitoring Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Therapeutic Drug Monitoring Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Therapeutic Drug Monitoring Market Share by Country (2021-2026) Table 111. Asia-Pacific Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Therapeutic Drug Monitoring Market Share Forecast by Country (2027-2032) Table 113. Latin America Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Therapeutic Drug Monitoring Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Therapeutic Drug Monitoring Market Share by Country (2021-2026) Table 116. Latin America Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Therapeutic Drug Monitoring Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Therapeutic Drug Monitoring Market Share by Country (2021-2026) Table 121. Middle East & Africa Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Therapeutic Drug Monitoring Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Therapeutic Drug Monitoring Product Image Figure 3. Global Therapeutic Drug Monitoring Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 5. Global Therapeutic Drug Monitoring Market Share by Region: 2025 VS 2032 Figure 6. Global Therapeutic Drug Monitoring Market Share by Region (2021-2032) Figure 7. North America Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Blood Test Image Figure 13. Global Blood Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Urine Test Image Figure 15. Global Urine Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Saliva Test Image Figure 17. Global Saliva Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Test Image Figure 19. Global Other Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Therapeutic Drug Monitoring Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Therapeutic Drug Monitoring Market Share by Type 2025 VS 2032 Figure 22. North America Therapeutic Drug Monitoring Market Size Share by Type (2021-2032) Figure 23. Europe Therapeutic Drug Monitoring Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Therapeutic Drug Monitoring Market Size Share by Type (2021-2032) Figure 25. Latin America Therapeutic Drug Monitoring Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Therapeutic Drug Monitoring Market Size Share by Type (2021-2032) Figure 27. Hospital Labs Image Figure 28. Global Hospital Labs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Private Labs Image Figure 30. Global Private Labs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Therapeutic Drug Monitoring Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Therapeutic Drug Monitoring Market Share by Application 2025 VS 2032 Figure 35. North America Therapeutic Drug Monitoring Market Size Share by Application (2021-2032) Figure 36. Europe Therapeutic Drug Monitoring Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Therapeutic Drug Monitoring Market Size Share by Application (2021-2032) Figure 38. Latin America Therapeutic Drug Monitoring Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Therapeutic Drug Monitoring Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Therapeutic Drug Monitoring Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Therapeutic Drug Monitoring Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Therapeutic Drug Monitoring Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 45. Europe Therapeutic Drug Monitoring Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Therapeutic Drug Monitoring Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 48. Asia-Pacific Therapeutic Drug Monitoring Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Therapeutic Drug Monitoring Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 51. Latin America Therapeutic Drug Monitoring Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Therapeutic Drug Monitoring Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 54. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Therapeutic Drug Monitoring Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Test
  • Urine Test
  • Saliva Test
  • Other Test
Applications
  • Hospital Labs
  • Private Labs
  • Others
Companies covered
  • Roche
  • Danaher
  • Abbott
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • BioMerieux
  • Sanquin
  • Becton Dickinson
  • Quest Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Therapeutic Drug Monitoring Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Therapeutic Drug Monitoring Market Size by Region (2021-2032)
  5. 1.4.1 Global Therapeutic Drug Monitoring Market Size by Region (2021-2026)
  6. 1.4.2 Global Therapeutic Drug Monitoring Market Size by Region (2027-2032)
  7. 1.5 Key Regions Therapeutic Drug Monitoring Market Size (2021-2032)
  8. 1.5.1 North America Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate (2021-2032)
2 Therapeutic Drug Monitoring Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Blood Test
  3. 2.1.2 Urine Test
  4. 2.1.3 Saliva Test
  5. 2.1.4 Other Test
  6. 2.2 Global Therapeutic Drug Monitoring Market Size by Type
  7. 2.2.1 Global Therapeutic Drug Monitoring Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Therapeutic Drug Monitoring Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Therapeutic Drug Monitoring Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Therapeutic Drug Monitoring Market Size by Regions
  11. 2.3.1 North America Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Type (2021-2026)
3 Therapeutic Drug Monitoring Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Labs
  3. 3.1.2 Private Labs
  4. 3.1.3 Others
  5. 3.2 Global Therapeutic Drug Monitoring Market Size by Application
  6. 3.2.1 Global Therapeutic Drug Monitoring Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Therapeutic Drug Monitoring Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Therapeutic Drug Monitoring Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Therapeutic Drug Monitoring Market Size by Regions
  10. 3.3.1 North America Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Therapeutic Drug Monitoring Industry Trends
  2. 4.2 Therapeutic Drug Monitoring Industry Drivers
  3. 4.3 Therapeutic Drug Monitoring Industry Opportunities and Challenges
  4. 4.4 Therapeutic Drug Monitoring Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Therapeutic Drug Monitoring Revenue (2021-2026)
  2. 5.2 Global Therapeutic Drug Monitoring Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Therapeutic Drug Monitoring Key Company Headquarters & Area Served
  4. 5.4 Global Therapeutic Drug Monitoring Company, Product Type & Application
  5. 5.5 Global Therapeutic Drug Monitoring Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Therapeutic Drug Monitoring Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Therapeutic Drug Monitoring Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Therapeutic Drug Monitoring Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Roche Therapeutic Drug Monitoring Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Danaher
  8. 6.2.1 Danaher Company Information
  9. 6.2.2 Danaher Business Overview
  10. 6.2.3 Danaher Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Danaher Therapeutic Drug Monitoring Product Portfolio
  12. 6.2.5 Danaher Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Abbott Therapeutic Drug Monitoring Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 Siemens Healthcare
  26. 6.5.1 Siemens Healthcare Company Information
  27. 6.5.2 Siemens Healthcare Business Overview
  28. 6.5.3 Siemens Healthcare Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio
  30. 6.5.5 Siemens Healthcare Recent Developments
  31. 6.6 Bio-Rad Laboratories
  32. 6.6.1 Bio-Rad Laboratories Company Information
  33. 6.6.2 Bio-Rad Laboratories Business Overview
  34. 6.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories Recent Developments
  37. 6.7 BioMerieux
  38. 6.7.1 BioMerieux Company Information
  39. 6.7.2 BioMerieux Business Overview
  40. 6.7.3 BioMerieux Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 BioMerieux Therapeutic Drug Monitoring Product Portfolio
  42. 6.7.5 BioMerieux Recent Developments
  43. 6.8 Sanquin
  44. 6.8.1 Sanquin Company Information
  45. 6.8.2 Sanquin Business Overview
  46. 6.8.3 Sanquin Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sanquin Therapeutic Drug Monitoring Product Portfolio
  48. 6.8.5 Sanquin Recent Developments
  49. 6.9 Becton Dickinson
  50. 6.9.1 Becton Dickinson Company Information
  51. 6.9.2 Becton Dickinson Business Overview
  52. 6.9.3 Becton Dickinson Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio
  54. 6.9.5 Becton Dickinson Recent Developments
  55. 6.10 Quest Diagnostics
  56. 6.10.1 Quest Diagnostics Company Information
  57. 6.10.2 Quest Diagnostics Business Overview
  58. 6.10.3 Quest Diagnostics Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio
  60. 6.10.5 Quest Diagnostics Recent Developments
7 North America
  1. 7.1 North America Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  3. 7.3 North America Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  3. 8.3 Europe Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  3. 10.3 South America Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Therapeutic Drug Monitoring Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst